Mesenchymal Stem/Stromal Cells Oral Abstracts
Friday, May 31, 2024 08:00 AM - 09:00 AM
Room 202-204
Mesenchymal Stem / Stromal Cells
Abstract Presentations
- Advancing Mesenchymal Cell-Based Bone Tissue Engineering: Comprehensive Phase II Clinical Trial Outcomes of BonoFill™ in Maxillofacial Reconstruction, Tomer Bronshtein, Israel
- Human Pluripotent Stem Cell-derived Mesenchymal Stromal Cells Genetically Engineered to Express Affimer® Proteins to Enhance the Immune Response, Sung Hyun Choi, Korea (the Republic of)
- Multiomic analysis of γMSC-suppressed alloreactive T cells, Kyndal Goss, United States
- An Open label, Single Arm, Phase I/II Study To Assess The Safety And Efficacy of Perianal Administration of STEMPEUCEL® (Adult Human Bone Marrow Derived, Cultured, Pooled, Allogenic Mesenchymal Stromal Cells) in Patients With Perianal Fistulizing Chron's Disease, Pawan K Gupta, India
- Regulatory science with generated insulin producing cells from ADSC toward first-in-human clinical trial, Tetsuya Ikemoto, Japan
- Real-World Data Suggest Effectiveness Of the Allogenic Stromal-Cells Preparation MSC-FFM IN Ruxolitinib-Refractory Or -Intolerant Acute Graft-Versus-Host Disease, Lisa-Marie Pfeffermann, Germany
